MRMD — Marimed Cashflow Statement

0.000.00%

Last trade - 00:00

Consumer DefensivesSpeculativeMicro CapContrarian

Annual cashflow statement for Marimed, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	7.22	13.5	-16	-12.2	-14.5
Depreciation
Amortisation
Non-Cash Items	19.2	11.1	16.7	1.67	4.87
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	6.69	-21.9	-1.29	6.42	5.8
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Taxes Payable
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Cash from Operating Activities	35.9	7.31	7.91	6.79	7.7
Capital Expenditures	-18.6	-12.7	-20.8	-12.7	-1.63
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	1.94	-13.5	-5.23	-4.46	0.252
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-16.6	-26.2	-26	-17.1	-1.38
Financing Cash Flow Items	-0.41	-2.26	-4.41	-0.139	-0.137
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	7.45	-1.01	23	2.98	-4.71
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	26.7	-19.9	4.91	-7.36	1.6